Archana Ayyar | Reproductive Biology | Best Researcher Award

Published on by Invention Awards

Dr. Archana Ayyar | Reproductive Biology | Best Researcher Award

University Hospitals, United States

Profile

ORCID

🧠 Early Academic Pursuits

Dr. Archana K. Ayyar began her academic journey with distinction, earning dual undergraduate degrees in Psychology (B.S.) and Finance (BBA) from The University of Texas at Austin between 2011 and 2015. During this time, she consistently earned accolades such as University Honors, College Scholar, and Dean’s Honor List recognitions. Her academic excellence led her to the prestigious Texas Tech University Health Science Center in Lubbock, where she pursued her Doctor of Medicine (M.D.) from 2015 to 2019. Her early interest in women’s health and research excellence was evident from her Outstanding Student of the Year (Ob/Gyn) award in 2019.

🩺 Professional Endeavors and Clinical Training

Dr. Ayyar’s medical training includes a Residency in Obstetrics and Gynecology (2019–2023) at Baylor College of Medicine, Houston, TX, followed by her current Fellowship in Reproductive Endocrinology and Infertility (2023–present) at University Hospitals, Case Western Reserve University, Cleveland, Ohio. Her trajectory through these prestigious institutions reflects her dedication to clinical excellence in women’s reproductive health.

🧬 Research Focus and Academic Contributions

Dr. Ayyar has demonstrated a deep commitment to research and scientific advancement in reproductive medicine. Her research has been recognized through multiple awards, including the 2022 President’s Presenter’s Research Award by the Society for Reproductive Investigators, and the First Place Oral Presentation at Baylor's Resident Research Day. Her areas of research have included reproductive endocrinology, infertility, adolescent gynecology, and transplantation, with recognition such as the Poster of Distinction at the American Transplant Congress.

🏆 Honors, Awards, and Distinctions

Dr. Ayyar’s commitment to excellence is reflected in a long list of honors:

  • 🥇 2024 Society’s Research Grant Award – CLESOG

  • 🏅 2023 “Ova-Achiever” Teaching Award – Baylor College of Medicine

  • 🎓 2018 Junior AOA Inductee – Texas Tech University

  • 🧠 2016 AATS Summer Intern Scholar – American Association for Thoracic Surgery

  • 💼 Multiple REI Resident Divisional Awards – 2021, 2023

These accolades span academic, research, and teaching domains, underlining her balanced and exceptional performance.

📚 Editorial and Scholarly Activities

Dr. Ayyar has served as an Ad Hoc Reviewer for Faculty Opinions (2021–2022) and reviewed manuscripts for leading journals such as Fertility and Sterility and Journal of Pediatric and Adolescent Gynecology. Her review of “Morris RS, F S Rep 2021” was published in Faculty Opinions, showing her role in shaping the academic discourse in her field. She worked closely under the mentorship of Dr. Schutt, further refining her academic acumen.

💡 Technical and Research Skills

Dr. Ayyar possesses a diverse range of technical and clinical skills, especially in the areas of:

  • Assisted reproductive technologies (ART)

  • Female endocrine disorders

  • Clinical data analysis and presentation

  • Medical education techniques
    Her ability to merge clinical insights with data-driven research continues to inform her practice and mentorship efforts.

👩‍🏫 Teaching and Mentorship Excellence

A natural educator, Dr. Ayyar has received multiple teaching awards, such as the Distinguished Educator’s Award and the “Ova-Achiever” Teaching Award, both from Baylor College of Medicine in 2023. She actively mentors residents and medical students, integrating clinical practice with evidence-based education.

🌐 Professional Societies and Network

She holds active memberships in several prestigious medical societies:

  • 🔬 Alpha Omega Alpha (AOA) – Full Member (2018–present)

  • 🩺 American College of Obstetrics and Gynecology (ACOG) – Junior Fellow

  • 🧪 Society for Reproductive Investigation

  • 🧬 American Society of Reproductive Medicine

These memberships not only enhance her access to cutting-edge research but also reflect her active engagement in advancing reproductive healthcare.

🔍 Impact and Influence

Dr. Ayyar’s contributions have significantly impacted the fields of Obstetrics, Gynecology, and Reproductive Medicine. Her work has influenced both clinical practices and educational frameworks. Through her research presentations, clinical excellence, and peer-reviewed contributions, she continues to shape the future of women’s health.

🌟 Legacy and Future Contributions

As she continues her fellowship, Dr. Ayyar is poised to become a leader in reproductive medicine, integrating innovation, compassion, and academic excellence. Her long-term vision includes mentoring future physicians, advancing ART techniques, and shaping policy and practice standards in reproductive endocrinology.

Selected Publications

Authors: Archana Ayyar, Marian Khalil, Maggie Wong, Rebecca Chung, Kathryn Coyne, Joseph Findley, Rachel Weinerman, Rebecca Flyckt, Katelyn Perroz Sofaly, Sung Tae Kim
Journal: Reproductive Medicine
Year: 2025
Additional considerations for hysteroscopic morcellation versus electric vacuum aspiration
Authors: Archana Ayyar, Steven R. Lindheim, Rebecca Flyckt
Journal: Fertility and Sterility
Year: 2024
Novel intragraft regulatory lymphoid structures in kidney allograft tolerance
Authors: Ivy A. Rosales, Chao Yang, Evan A. Farkash, Tameem Ashry, Jifu Ge, Imad Aljabban, Archana Ayyar, Dorothy Ndishabandi, Rebecca White, Elena Gildner, et al.
Journal: American Journal of Transplantation
Year: 2022
Management of a Novel Autoimmune Disease, COPA Syndrome, in Pregnancy
Authors: Archana Ayyar, Rachel D. Seaman, Kalpalatha Guntupalli, Mary C. Tolcher, Daniel Martin
Journal: Case Reports in Obstetrics and Gynecology
Year: 2022

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Published on by Invention Awards

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

🎓 Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

🎓 Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

👨‍🏫 Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 – PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 – B.Pharm & PHT 417 – PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 – PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

🏢 Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

🏛️ Council & Committee Memberships

Pharmaceutics Department Council Member – (2017–Present)

Academic Committee Member – College of Pharmacy (2017–2018)

Annual Research Day Committee Member – (2017–2018)

🔬 Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

🏆 Awards & Recognitions

Distinction Award for Academic Excellence – Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award – University of Alberta (2014)

Graduate Students' Association Academic Travel Award – University of Alberta (2015, 2016)

CSPS Meeting Travel Award – Faculty of Pharmacy, University of Alberta (2015, 2016)

🎓 Licenses & Certifications

Licensed Pharmacist – Saudi Commission for Health Specialties (SCFHS) (2010–Present)

📜 Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.

 

 

Dr. Giuseppe Lodi | Dermatology | Best Researcher Award

Published on by Invention Awards

Dr. Giuseppe Lodi | Dermatology | Best Researcher Award

University of Campania “Luigi Vanvitelli”, Dermatologic Unit, Italy.

Dr. Giuseppe Lodi is an Italian Medical Doctor specializing in Dermatology and Venereology. With extensive experience in clinical practice and research, he is currently a resident at the University of Campania "Luigi Vanvitelli" and a practicing physician at Dimed Srl. His expertise spans laser treatments, photomedicine, and dermatological innovations, making him a recognized figure in the field.

Profile

Scopus

🎓 Education

Dr. Giuseppe Lodi pursued his Degree in Medicine and Surgery from the University of Naples "Federico II" in 2012, laying the foundation for his medical career. In 2016, he completed the General Practitioner Program Training in Campania Region, Italy, where he focused on Dermatology in General Medicine for his thesis. His passion for dermatological advancements led him to earn a Level II Master’s in Lasers and Light Sources for Dermatology from the University of Rome Tor Vergata in 2018, achieving a final grade of 110/110 with honors. His academic journey reflects a strong commitment to excellence and innovation in dermatology.

💼 Experience

Dr. Giuseppe Lodi is currently a Dermatology and Venereology Resident at the University of Campania "Luigi Vanvitelli", Italy (2021 – Present), where he specializes in the diagnosis and treatment of skin diseases and sexually transmitted infections. Alongside his residency, he serves as a Medical Doctor at Dimed Srl, Italy (2021 – Present), a medical center affiliated with the National Health Service, providing patient care and dermatological consultations.

Previously, in 2020, he held the prestigious role of Lieutenant Medical Officer at IMAS – Aerospace Medicine Institute "Aldo di Loreto", within the Italian Air Force. In this capacity, he was responsible for the medical evaluation and healthcare of military personnel, further broadening his expertise in medical disciplines beyond dermatology. His diverse experience showcases his dedication to both clinical practice and specialized dermatological research.

🔬 Research Interests

Lasers and Light-Based Dermatological Treatments

Photomedicine and Blue Light Therapy

Psoriasis and Acne Treatment Innovations

Aesthetic and Clinical Dermatology

🏆 Awards

🥇 1st Prize for Young Researchers Poster – La Scuola della Psoriasi V Congresso (2019)

🥇 1st Prize for Young Researchers Poster – ADECA (2020)

🏅 Best Clinical Case Award – V Congresso Dermatologia Coast to Coast (2023)

🎖 Prize ADECA Young (2023) – Microneedling Radiofrequency for Acne Vulgaris

📚 Publication

📖 Microneedling Radiofrequency for Acne Vulgaris in Adolescents as a Promising Device-Based Treatment: A Clinical Case Series

G. Lodi, I. Fusco, T. Zingoni, G. Cannarozzo, M. Sannino

📅 2025 | 📜 Photobiomodulation, Photomedicine, and Laser Surgery

 

 

 

Dr. Jad El Masri | Medical Research | Young Scientist Award

Published on by Invention Awards

Dr. Jad El Masri | Medical Research | Young Scientist Award

American University of Beirut, Lebanon.

Dr. Jad El Masri is a postdoctoral research fellow at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. With a strong background in clinical research, pathology, and neuroscience, he has contributed significantly to oncology, epidemiology, and neurosurgery. Holding an MD and multiple master’s degrees, he is set to complete his PhD in Clinical Research and Pathology in 2025. With over 45 completed research projects and 43 publications, Dr. El Masri has been recognized for his work in cancer biomarkers, epidemiological risk factors, and computational biology.

Profile

Google Scholar

🎓 Education

Dr. Jad El Masri has a diverse academic background spanning clinical research, pathology, neuroscience, and medical sciences. He is currently completing his PhD in Clinical Research & Pathology at Université Paris-Est (2022–2025) while holding multiple master’s degrees in Human Morphology, Clinical Investigation, and Neuroscience from leading institutions, including the American University of Beirut and Lebanese University. In addition, he earned his Medical Degree (MD) from Lebanese University (2018–2024) and holds a Biochemistry License Degree (2017–2020). His academic journey began with a French Baccalaureate in Science from Rawdat Fayhaa Secondary School (2001–2016).

💼 Experience

Dr. Jad El Masri is currently a Postdoctoral Research Fellow at the Broad Institute of MIT & Harvard (2025–Present) and Dana-Farber Cancer Institute (2024–Present), where he focuses on oncology and computational biology. His clinical experience includes multiple internships across hospitals in Lebanon and Germany (2022–2024), gaining hands-on expertise in various medical disciplines. Additionally, he completed elective neurosurgery rotations at the American University of Beirut Medical Center (AUBMC) and Medizinische Hochschule Hannover, further strengthening his specialization in neurosurgery and brain cancer research.

🔬 Research Interests

Oncology – Brain cancer, genetic biomarkers, metastasis

Epidemiology – Risk factors, diet effects, environmental exposure

Neurosurgery – Computational biology, single-cell DNA sequencing

🏆 Awards & Recognitions

Young Scientist Award – Recognized for contributions to neuroscience research

Editorial Board Member – Journal of Public Health Research

Professional Memberships – European Stroke Organization, Congress of Neurological Surgeons

📚 Selected Publications

1️⃣ Social media medical misinformation: Impact on mental health and vaccination decision among university students
📖 Irish Journal of Medical Science (1971-), 192(1), 291-301 (2023)
📄 DOI | Cited by: 34

2️⃣ Menstrual abnormalities post-COVID vaccination: A cross-sectional study on adult Lebanese women
📖 Irish Journal of Medical Science (1971-), 192(3), 1163-1170 (2023)
📄 DOI | Cited by: 27

3️⃣ Contribution of Arab world in transplant research: A PubMed-based bibliometric analysis
📖 Transplant Immunology, 101432 (2021)
📄 DOI | Cited by: 23

4️⃣ Cancer research activity in the Arab world: A 15-year bibliometric analysis
📖 Journal of the Egyptian Public Health Association, 97(1), 26 (2022)
📄 DOI | Cited by: 22

5️⃣ Contribution of Arab countries to familial Mediterranean fever research: A PubMed-based bibliometric analysis
📖 Rheumatology International, 42(1), 95-100 (2022)
📄 DOI | Cited by: 22

 

 

 

 

Dr. Panupong Hansrivijit | Nephrology | Best Researcher Award

Published on by Invention Awards

Dr. Panupong Hansrivijit | Nephrology | Best Researcher Award

Brigham and Women's Hospital, United States.

Dr. Panupong (Ben) Hansrivijit, MD, is a dedicated nephrology fellow at Brigham and Women’s Hospital/Massachusetts General Hospital, Boston, MA. With a stellar academic background, including an MD with first-class honors from Chulalongkorn University, Dr. Hansrivijit focuses on advancing care for kidney-related conditions. His clinical expertise spans chronic kidney disease, dialysis, and kidney transplantation, alongside a robust research portfolio in nephrology and public health.

Profile

Google Scholar

🎓 Education

Dr. Panupong Hansrivijit is a nephrology fellow at Brigham and Women’s Hospital/Massachusetts General Hospital (2022–2026) and a Master of Public Health candidate at Harvard T.H. Chan School of Public Health (2023–2025). He completed his Internal Medicine Residency at UPMC Harrisburg (2019–2022) and earned his MD with First Class Honors from Chulalongkorn University, Thailand (2016). Dr. Hansrivijit is committed to advancing nephrology and public health through patient care and research.

🏥 Experience

Dr. Panupong Hansrivijit is a dedicated nephrology fellow at Brigham and Women’s Hospital/Massachusetts General Hospital (2022–2026), specializing in kidney care, dialysis, and transplant evaluations. He previously honed his clinical and research expertise during his Internal Medicine Residency at UPMC Harrisburg (2019–2022) and built a strong foundation in patient care as an Internal Medicine Intern at Thammasat University Hospital (2016–2019). Dr. Hansrivijit is passionate about advancing nephrology through clinical excellence and research innovation.

🔬 Research Interests

Chronic kidney disease

Dialysis and dialysis access

Kidney transplantation

Acute kidney injury

Nephrotic syndrome

Hypertension

Pharmaco-epidemiology

🏆 Awards

American Board of Internal Medicine Certification (2022–2032)

Medical License (Massachusetts, 2022–2025)

📚 Selected Publications

Utilization Trends of Tirzepatide, Glucose-Lowering Medications, and Anti-Obesity Medications in Patients with CKD with and without Type 2 Diabetes: SA-PO327
Journal of the American Society of Nephrology, 35 (10S), 10.1681, 2024
Co-authored with J. Ortega-Montiel, D.J. Wexler, E. Patorno, and J.M. Paik, this study explores medication trends in patients with chronic kidney disease (CKD) and type 2 diabetes.

1403-P: Prescribing Trends of Glucose-Lowering Medications among Adult Kidney Transplant Recipients with Type 2 Diabetes—A US Population-Based Cohort Study
Diabetes, 73 (Supplement_1), 2024
In this population-based study, Dr. Hansrivijit, along with collaborators E. Patorno, D.J. Wexler, R. Abdi, and J.M. Paik, examines trends in glucose-lowering medication prescriptions among kidney transplant recipients.

Improvement of Calcinosis Cutis With Sodium Thiosulfate Infusion in a Peritoneal Dialysis Patient: SA-PO338
Journal of the American Society of Nephrology, 33 (11S), 697-698, 2022
A study co-authored with V.S. Iyer, highlighting the therapeutic effect of sodium thiosulfate in treating calcinosis cutis in a peritoneal dialysis patient.

Re: Incidence and Characteristics of Kidney Stones in Patients on Ketogenic Diet: A Systematic Review and Meta-Analysis
Journal of Urology, 207 (2), 462-463, 2022
Dr. Hansrivijit contributed to a meta-analysis investigating kidney stone incidences in patients following a ketogenic diet.

Hyperuricemia is Associated With Increased Mortality in Heart Failure Patients With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
This study investigates the link between hyperuricemia and mortality risk in heart failure patients with preserved ejection fraction.

 

 

Prof. Dr. Sultan Abdulwadoud Alshoabi | Radiologist | Best Researcher Award

Published on by Invention Awards

Prof. Dr. Sultan Abdulwadoud Alshoabi | Radiologist | Best Researcher Award

Taibah University, Saudi Arabia.

Sultan Abdulwadoud Alshoabi is a Clinical Radiologist and Professor of Diagnostic Radiology with over 11 years of experience in the field. He holds an MBBS, MD, and specialized certifications from the Jordanian and Arab Boards in Diagnostic Radiology. With a proven ability to enhance the work environment, Sultan is not only skilled in conducting and supervising research but is also proficient in ultrasonography and sectional anatomy education. His contributions to the medical field and expertise in Radiology make him a respected figure in his profession.

Profile

Orcid

Google Scholar

Education 🎓

Sultan Alshoabi completed his MBBS at the Faculty of Medicine and Health Sciences, Sana'a University (1994-2001), before pursuing further specialization in Radiology. He received his MD from the Jordanian Medical Council in August 2014, specializing in Diagnostic Radiology. Additionally, he achieved the Arab Board certification (MD) in Radiology and Medical Imaging in February 2013, under the Arab League and the Arab Board of Health Specializations.

Experience 🏥

With more than a decade of experience, Sultan has worked as a Radiologist and Professor of Radiology. He has taught Radiology and Sectional Anatomy and conducted and supervised research projects. Sultan has also conducted ultrasonography examinations, with a vast range of expertise in conventional X-rays, fluoroscopy, computed tomography (CT), and magnetic resonance imaging (MRI), consistently demonstrating his ability to write comprehensive diagnostic reports.

Research Interests 🔬

Diagnostic Radiology & Medical Imaging
Sultan’s primary research interest lies in the area of diagnostic radiology, focusing on improving the accuracy and effectiveness of diagnostic practices. He aims to refine imaging techniques, which are essential for diagnosing various medical conditions, thereby enhancing patient care.

Improving Work Environment in Medical Institutions
A significant portion of Sultan’s research addresses improving the work environment within healthcare settings. His work emphasizes optimizing workflows, increasing efficiency, and ensuring a safer, more effective work atmosphere for radiologists and medical staff.

Advancing Technology Integration in Healthcare
Sultan is keen on integrating advanced technology into the field of healthcare, particularly in medical imaging. His research seeks to explore the latest diagnostic tools and imaging technologies to improve diagnostic outcomes and provide cutting-edge medical services.

Advancing Education for Radiologists
Another core interest of Sultan’s research is the advancement of radiology education. He strives to innovate and improve teaching methods for radiology and sectional anatomy, ensuring that the next generation of radiologists is well-equipped with the latest knowledge and skills needed for their practice.

Publications Top Notes 📚

"Demographic Profiles, Etiological Spectrum, and Anatomical Locations of the Post-Hepatic Obstructive Jaundice in Adult Population in Hadhramout Region in Yemen". Journal: Diseases, Published: 2024-12-19, Link

"Cardiac amyloidosis: A diagnostic challenge". , Journal: Radiology Case Reports, Published: 2024-11. Link

"Efficacy of B-mode and elastography ultrasound technique in the prediction of Helicobacter pylori: a prospective study". Journal: BMC Gastroenterology, Published: 2024-11-28. Link

"Knowledge and Attitudes Regarding Crimean-Congo Hemorrhagic Fever Among Slaughterhouse Workers in Sana’a and Dhamar Cities-Yemen: A Cross-Sectional Study".  Journal: Journal of Multidisciplinary Healthcare, Published: 2024-08. Link

"Behçet's Syndrome With Multiple Bilateral Pulmonary Aneurysms Associated With Endomyocardial Fibrosis Presented With Pulmonary Emboli: A Case Report". Journal: Cureus, Published: 2024-08-06. Link

 

Dr. Alaa Sayed | Cardiovascular Medicine | Best Researcher Award

Published on by Invention Awards

Dr. Alaa Sayed | Cardiovascular Medicine | Best Researcher Award

UPMC, United States.

Alaa A. Sayed is a dedicated physician and researcher specializing in internal medicine and regenerative medicine. Currently serving as the Chief Resident in Internal Medicine at UPMC Mercy Hospital in Pittsburgh, Pennsylvania, Alaa's career spans significant roles across clinical practice, research, and global health initiatives. Her work at institutions like the University of Pittsburgh and the World Health Organization reflects her commitment to patient safety and medical innovation.

Profile

Orcid

Google Scholar

Education 🎓

Alaa earned her MBBCh with honors from Beni Suef University, Egypt, demonstrating her early commitment to medical excellence. She further specialized in regenerative medicine by completing a Master’s degree in Novel Therapeutics from Imperial College London. Her research focused on pioneering cardiac stem cell therapies, reflecting her dedication to advancing innovative treatments in cardiovascular health.

Experience 💼

Alaa brings a wealth of experience across various medical and research roles. She served as an Internal Medicine Chief Resident at UPMC Mercy Hospital, where she honed her clinical leadership skills. At the McGowan Institute for Regenerative Medicine, she contributed as a Research Fellow, deepening her expertise in regenerative therapies. Her career also includes a tenure as a Visiting Research Scholar at the University of Missouri and work as a Quality and Patient Safety Consultant with the World Health Organization. Alaa’s dedication to community health is evident in her role as a Primary Care Physician with the Egyptian Ministry of Health.

Research Interests 🔬

Research Specializations: Regenerative Medicine, Patient Safety, and Quality Care
Alaa’s research is deeply rooted in advancing regenerative medicine, particularly focusing on patient safety and quality care. Her work emphasizes the potential of stem cell therapies, striving to bridge the gap between innovative treatments and effective clinical practices.

Technical Expertise: Dry and Wet Lab Techniques
Alaa is highly skilled in both dry and wet lab methodologies, with extensive experience in cultivating and manipulating stem cell cultures. Her technical acumen extends to bioinformatics and AI-driven analysis, where she applies advanced algorithms to enhance diagnostic and therapeutic outcomes.

AI in Healthcare: Deep Learning and Performance Validation
Alaa’s work frequently intersects with thematic analysis and the validation of deep learning models tailored for healthcare. Her research aims to optimize performance metrics of AI applications, ensuring accurate, reliable, and patient-centered results.

Awards 🏆  

Alaa has been recognized for her excellence in patient safety research, and her contributions have been honored by organizations like the WHO and UPMC.

Her awards reflect her impact on improving patient care and advancing medical research.

Publications Top Notes 📚

Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Authors: A. Elgebaly, I. A. I. Radwan, M. M. AboElnas, H. H. Ibrahim, M. F. M. Eltoomy,
Journal: Journal of Gastrointestinal & Liver Diseases, 26(1), 2017. Citations: 89. Link

Functional Microvascularization of Human Myocardium In Vitro
Authors: O. King, D. Cruz-Moreira, A. Sayed, F. Kermani, W. Kit-Anan, I. Sunyovszki,
Journal: Cell Reports Methods, 2(9), 2022. Citations: 24. Link

Implementation Research on Measuring Quality in Primary Care: Balancing National Needs with Learning from the Eastern Mediterranean Region
Authors: M. Letaief, L. R. Hirschhorn, S. Leatherman, A. A. Sayed, A. Sheikh, S. Siddiqi
Journal: International Journal for Quality in Health Care, 33(3), mzab119, 2021. Citations: 7. Link

Vascularized Myocardium-On-A-Chip: Excitation-Contraction Coupling in Perfused Cardiac Co-Cultures
Authors: O. King, D. Cruz-Moreira, S. W. Kit-Anan, A. Sayed, B. Wang, J. Fourre,
Journal: Biophysical Journal, 118(3), 410a, 2020. Citations: 2. Link

Long-Term Association of Low-Density Lipoprotein Subtypes with Coronary Artery Calcium Score and Atherosclerotic Cardiovascular Disease Events: Insights from HeartSCORE Study
Authors: A. Sayed, J. Swanson, K. Kip, E. K. Jesrani, S. Reis, A. Saeed
Journal: Journal of Clinical Lipidology. Link

 

 

 

 

Hygon Mutavhatsindi | Infectious Diseases | Best Researcher Award

Published on by Invention Awards

Dr. Hygon Mutavhatsindi | Infectious Diseases | Best Researcher Award

Specialist Scientist, SAMRC, South Africa.

Hygon Mutavhatsindi is a Specialist Scientist at the South African Medical Research Council (SAMRC) with a robust background in biochemistry, molecular biology, and immunology. His research explores infectious diseases, particularly tuberculosis (TB), HIV, and COVID-19, using molecular and immunological techniques. Dr. Mutavhatsindi has made significant contributions to immunology and TB research, aiming to identify non-sputum biomarkers to improve TB diagnosis and treatment outcomes. His work has earned him national and international recognition, alongside numerous grants and awards.

Profile

Scopus

Orcid

Education 🎓

Dr. Hygon Mutavhatsindi began his academic journey at the University of Venda, where he earned a BSc in Biochemistry and Biology (2009-2012), followed by an Honours degree in Biochemistry in 2013. He continued to pursue advanced studies at the same institution, obtaining an MSc in Biochemistry (2014-2015). His passion for molecular biology led him to Stellenbosch University, where he completed his PhD in Molecular Biology (2016-2019). During his doctoral studies, Dr. Mutavhatsindi focused on cutting-edge research, contributing to scientific advancements in his field.

Following his PhD, Dr. Mutavhatsindi undertook a prestigious Postdoctoral Fellowship in Immunology at the University of Cape Town (2020-2023). During this period, he deepened his expertise in immunological research, working on projects that explored the intricate mechanisms of immune response. His postdoctoral work not only advanced his academic credentials but also positioned him at the forefront of immunological science, further strengthening his research profile and contributing to ongoing scientific discussions in molecular biology and immunology.

Experience 💼

Dr. Hygon Mutavhatsindi currently serves as a Specialist Scientist at the South African Medical Research Council (SAMRC), a role he began in February 2024. In this position, he leads research efforts in tuberculosis (TB) and immunology, supervises postgraduate students, and manages multiple research projects. Prior to this, he was a Scientific Officer at the Cape Town HVTN Immunology Laboratory (May 2023–January 2024), where he conducted clinical studies and flow cytometry experiments, contributing to crucial immunological research.

Before taking on these roles, Dr. Mutavhatsindi completed a Postdoctoral Research Fellowship at the University of Cape Town (February 2020–January 2023), where his work focused on TB and COVID-19 immunology. His academic journey began as a PhD Researcher at Stellenbosch University (June 2016–December 2019), where he specialized in identifying TB biomarkers and evaluating treatment responses, building a strong foundation for his later contributions to immunology and infectious disease research.

Research Interests 🔬

TB Biomarkers: Focuses on identifying reliable biomarkers for tuberculosis diagnosis and monitoring treatment efficacy.

Non-Sputum Diagnostic Methods: Investigates blood- and saliva-based biomarkers to develop non-sputum diagnostic alternatives for TB, making diagnosis easier in low-resource settings.

Immunological Responses: Studies the immune system’s response to infectious diseases, with an emphasis on TB, HIV, and COVID-19.

Infectious Disease Immunology: Explores the interactions between pathogens and host immune responses to enhance understanding of disease progression and treatment outcomes.

TB Treatment Monitoring: Aims to develop new methods for tracking patient progress during TB treatment through biomarker discovery.

Cross-Disease Immunology: Compares immune responses across different infectious diseases, seeking common biomarkers and pathways for broader diagnostic and therapeutic applications.

Awards 🏆

Awards and Grants:

UCT CIDRI-Africa Postdoctoral Fellowship (2020-2022)

Fogarty HIV-Associated TB Training Program (2020-2022)

NRF Postdoctoral Fellowship (2021-2022)

SAMRC Doctoral Internship Scholarship (2017-2019)

NRF PhD and Masters Scholarships

Publications Top Notes 📚 

Validation and optimisation of host immunological bio-signatures for a point-of-care test for TB disease – Front. Immunol., 2021. link

Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis – Tuberculosis, 2021. link

Protocol to quantify and phenotype SARS-CoV-2 specific T-cell response – Star Protocols, 2022. link

Blood and site of disease inflammatory profiles in HIV-1-infected pericardial tuberculosis patients – OFID, 2023. link

Application of cerebrospinal fluid host protein biosignatures in the diagnosis of tuberculous meningitis in children – Mediators of Inflammation, 2019. link